Endogenic and iatrogenic diabetes mellitus in drug-nave schizophrenia: The role of olanzapine and its place in the psychopharmacological treatment algorithm

Neuropsychopharmacology

Volumn 36, Issue 11, 2011, Pages 2368-2369

  Cohen, Dan ^a,b   De Hert, Marc ^c  

^a Mental Health Care North Holland North ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

ALGORITHM; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; IATROGENIC DISEASE; LETTER; METABOLIC DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE;

EID: 80052770466     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.94     Document Type: Letter

References (6)

1. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA et al (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36: 71-93.
2. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K (2008). The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51: 2187-2196.
3. Cohen D (2006). Diabetes mellitus in schizophrenia or schizo-affective disorder: an iatrogenic or endogenic problem? (thesis), Haarlem, Netherlands. ISBN: 90-808509-3-4.
4. De Hert M, Detraux J, van Winkel R, Correll C (2011). Anti-psychotic medications: metabolic, cardiovascular and cardiac risks. Nature Rev Endocr (in press).
5. Nielsen J, Skadhede S, Correll CU (2010). Antipsychotics associated with the development of type 2 diabetes in antipsycho-tic-nä?ve schizophrenia patients. Neuropsychopharmacology 35: 1997-2004.
6. Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Asenjo Lobos C et al (2010). Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123: 225-233.